PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 23 No. 11
Pages: 1  2  
Previous
 

Understanding and Using the Placebo Effect

By Walter A. Brown, MD | October 1, 2006

Using placebos in practice

How should we, as practicing psychiatrists, use this information to make the most of the placebo effect? Jerome Frank16 wrote about the curative elements of placebo treatment. He believed that because no one has been able to demonstrate a substantial difference in the outcome of different psychotherapies, the active components of psychotherapy are the components that are common to all the psychotherapies and to placebo treatment. He also suggested that the curative elements of placebo and psychotherapy begin with a person in distress who goes to an expert for help. The expert provides an explanation for the condition, and the patient undergoes a healing ritual (Table 3, see Psychiatric Times, October 2006, p 16). The stronger the healer's belief in the ritual, the more likely it is to work. This is why it is good to have a theory about what you are doing, even if the theory is wrong.

If we consider the placebo effect as one of the components of healing, we can feel more comfortable applying it. In fact, most of us do many of the required things intuitively (Table 4). For example, we inspire confidence by dressing in attire that most patients consider more appropriate for an office than for the garden. We display our diplomas and certificates where patients can see them.

Table 4
Harnessing the placebo effect
Inspire confidence
Look and dress like a physician
Display signs and symbols of healing
Use symbols of healing
Make notes in medical chart
Use a prescription pad
Evaluate
Listen
Take time
Ask questions
Perform or order simple diagnostic tests
 
Provide a diagnosis
Explanation for symptoms
Need not be from DSM-IV
 
Enhance response to treatment
Elicit patient's beliefs about treatment
Select treatment that is consistent with patient beliefs
Consider concomitant alternative therapy
Use treatment that has worked before
Offer optimistic prognosis
Use prescription pad

When we evaluate patients, it is important to take the time to listen and ask questions, even when we might not need the answers to those questions. This behavior gives patients the security of knowing that you are paying careful attention. An internist may know immediately when a patient walks through the door that he has bronchitis. Nonetheless, the physician performs chest auscultation and has at least a brief conversation with that patient before discussing treatment. Psychiatrists do not order routine blood tests in as many patients as our internal medicine colleagues do, but we do order tests if we have any reason to believe the results could be helpful. Simple tests go a long way toward making people believe they are cared for.

Providing a diagnosis is also crucial, even if it is not a diagnosis from DSM-IV. People benefit from getting an explanation for their distress. It brings the problem down to size and makes their suffering seem more manageable.

Suggesting honest, appropriate, and positive expectations about a patient's illness can be worthwhile. If you give a patient with a backache an analgesic, you maximize the chances of a good response by saying: "This is a powerful painkiller. It's going to help you." Saying, "Try this, it may work," is less helpful. It is essential to tell people with anxiety conditions, particularly panic disorder, that you expect the benzodiazepine you prescribe to make them feel better very quickly. If you prescribe an antidepressant, explain that the patient may have some nausea or a dry mouth initially, but that you fully expect him or her to feel much better in a few weeks.

Do you know what your patients believe about their illnesses? To provide the most effective care, you need to understand what they think they may have and what they think might help. If a patient is convinced that he needs a medication his cousin received, you'll have difficulty in getting him to discuss cognitive therapy. Once you know the patient's point of view, it is easier to work with it or attempt to persuade him to your point of view. An alternative therapy that the patient believes will be helpful can be given in conjunction with conventional therapy. Herbal teas, acupuncture, or massage are some examples.

When might you prescribe placebos?

I would not recommend that a psychiatrist prescribe a placebo for a depressed or anxious patient and tell him that it is an active drug. In some circum-stances, however, a patient has a condition that is highly placebo-responsive, such as mild depression or an anxiety disorder, and is reluctant to take medication. In such a situation, if your judgment is that the patient is not likely to suffer significant harm from a delay of several weeks before taking a conventional medication, you could say, "I know you don't want to take an SSRI, so I would suggest you try this pill (or herbal tea, or exercise regimen). We don't know how these treatments work. The pill contains no medicine, but a lot of people get better while taking it. It may stimulate the body's own healing processes, or it may do something else. If you're not feeling better in a few weeks, we should reconsider the SSRI."

Conclusion

What we call the placebo response is probably a complex interaction of expectation, conditioning, endorphin effects, and distress relief. Our role as psychiatrists is to be aware of the conditions in which the placebo response may be likely to play a strong role in recovery. We have an important part to play in inspiring confidence, evaluating the patient and providing a diagnosis, and enhancing the treatment response. Many of these facets of the placebo response are components of "bedside manner." We do not need to have a full understanding of how the placebo response works in order to harness some of its benefits in practice.

Dr Brown is clinical professor of psychiatry at Brown Medical School, Providence, RI, and Tufts University School of Medicine, Boston, and a practicing psychiatrist. Dr Brown reports no conflicts of interest concerning the subject matter of this article. This article is based on a presentation at the US Psychiatric and Mental Health Congress, Las Vegas, November 7-10, 2005.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





Drugs Mentioned in This Article
Alprazolam (Xanax)
Atenolol (Tenormin)
Fluoxetine (Prozac)
Imipramine (Tofranil)
Naloxone (Narcan)

Evidence-based References

  • Khan A, Kolts RL, Rapaport MH, et al. Magnitude of placebo response and drug-placebo differences across psychiatric disorders. Psychol Med. 2005;35:743-740.
  • Sox HC Jr, Margulies I, Sox CH. Psychologically mediated effects of diagnostic tests. Ann Intern Med. 1981; 95:680-685.

References:

1. Khan A, Kolts RL, Rapaport MH, et al. Magnitude of placebo response and drug-placebo differences across psychiatric disorders. Psychol Med. 2005;35:743-740.
2. Rosenbaum JD, Moriz GM, Bowden CL. Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. J Clin Psychopharmacol. 1997;17: 390-400.
3. Brown WA, Johnson MF, Chen M. Clinical features of depressed patients who do and do not improve with placebo. Psychiatry Res. 1992;41:203-214.
4. Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry. 1989;46:971-982.
5. Prioleau L, Murdock M, Brody N. An analysis of psychotherapy versus placebo studies. Behav Brain Sci. 1983;6:275-310.
6. Robinson LA, Berman JS, Niemeyer RA. Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull. 1990; 108:30-49.
7. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
8. Sox HC Jr, Margulies I, Sox CH. Psychologically mediated effects of diagnostic tests. Ann Intern Med. 1981; 95:680-685.
9. Swinburn BA, Walter LG, Arroll B, et al. The green prescription study: a randomized controlled trial of written exercise advice provided by general practitioners. Am J Public Health. 1998;88:288-291.
10. Kirsch I. Specifying nonspecifics: psychological mechanisms of placebo effects. In: Harrington A, ed. The Placebo Effect: An Interdisciplinary Exploration. Cambridge, Mass: Harvard University Press; 1997.
11. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia--imaging a shared neuronal network. Science. 2002;295:1737-1740.
12. de la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science. 2001;293:1164-1166.
13. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003;23:4315-4323.
14. Suchman AL, Ader R. Classic conditioning and placebo effects in crossover studies. Clin Pharmacol Ther. 1992;52:372-377.
15. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry. 2002;159:728-737.
16. Frank JD, Frank JB. Persuasion and Healing: A Comparative Study of Psychotherapy. 3rd ed. Baltimore: Johns Hopkins University Press; 1991.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Grief and Depression: The Sages Knew the Difference
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Ethical and Legal Issues in Geriatric Psychiatry
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy